The global hemorrhoid treatment market size is expected to be valued at USD 802.73 million in 2024 and USD 1064.14 million by 2029, growing at a CAGR of 5.8% during the forecast period.
Hemorrhoids are also known as piles which are swollen veins in the anus and lower rectum. Hemorrhoids are similar to varicose veins, which can develop inside the rectum and are known as internal hemorrhoids. When developed under the skin around the anus called external hemorrhoids. The symptoms include pain or discomfort, itching, swelling, bleeding in case of external hemorrhoids, and painless bleeding, pain, and irritation in internal hemorrhoids.
According to a Medscape report in 2022, the prevalence of symptomatic hemorrhoids is estimated at 4.4% in the general population. It also stated that in the United States, up to one-third of the 10 million people with hemorrhoids seek medical treatment, resulting in 1.5 million prescriptions per year. National Library of Medicine released an article regarding the outpatient survey at UoGCSH, Ethiopia, in 2021, where the results stated that the prevalence of hemorrhoids is higher in males than females. It also stated that constipation and overweight are found to increase the odds of having hemorrhoids. The increasing adoption of the sedentary lifestyle, which involves an unhealthy diet, is impacting people with obesity and constipation, which leads to the prevalence of hemorrhoids seeking medical treatment. There is growing awareness among people regarding the medical condition of hemorrhoids and the availability of treatment options. All these factors enhance the adoption of hemorrhoid treatment, raising the global market growth.
The growing techno advancements in the healthcare industry are driving the global market revenue with innovative and minimally invasive procedures for treating hemorrhoids. The increasing investments by the market players in the research activities allow them to focus on developing innovative and effective treatment procedures that fuel the hemorrhoid treatment market share in the forecast period.
The growing government initiatives to spread awareness among the people regarding hemorrhoids and treatment options will provide market growth opportunities in the forecast period. The increasing healthcare expenditure worldwide due to emerging economies is expected to augment the hemorrhoid treatment market in the upcoming years. The rising availability of over-the-counter products for treating hemorrhoids supports the hemorrhoid treatment market. These OTC products are estimated to offer convenience and ease of access to the treatment, which enhances the growth of the hemorrhoid treatment market.
The primary factor restraining the global hemorrhoid treatment market is the side effects associated with hemorrhoidectomy, including pain, bleeding, infection, fecal incontinence, and constipation, which are expected to hamper the global market expansion. The recovery time of the hemorrhoid surgery is expected to be 2 to 4 weeks when the patient faces pain or aches during the recovery period, which is expected to limit the adoption of hemorrhoid treatment. The presence of other alternative procedures, such as homeopathy, changing lifestyle, and diet, are expected to hinder the growth of the global hemorrhoid treatment market.
The need for awareness and skilled professionals for the treatment of hemorrhoids is challenging for the market expansion due to limited professionals for a huge number of patients. The availability of other treatment plans for hemorrhoid treatment, such as lifestyle changes with high fiber intake, is expected to impede the global market expansion by reducing the demand for hemorrhoid treatment products and services.
The Pandemic had a massive impact on the global hemorrhoid treatment market because the lockdown restrictions led to supply chain disruptions and production delays. The complete focus of healthcare on emergency COVID-19 cases by canceling the other non-emergency cases to avoid the spread of disease impacted the hemorrhoid patients where the symptoms and patient well-being deteriorated. According to a research study titled "Impact of COVID-19 Quarantine on Advanced Hemorrhoidal Disease and the Role of Telemedicine in Patient Management", COVID-19 delays influenced the deterioration of hemorrhoidal symptoms. Weight loss and lifestyle changes are critical factors in disease severity.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Treatment Type, Device Type, Type, Distribution Channel, End-Use, And Region. |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
Market Leader Profiled |
Boston Scientific Corporation, Medtronic Plc, Cook Medical, Integra LifeSciences, CONMED Corporation, Johnson & Johnson, Allergan, GlaxoSmithKline plc, Pfizer Inc., Taro Pharmaceuticals. |
The non-surgical procedures segment held the largest market share in the global market. Cryotherapy, infrared coagulation, and radiofrequency are the most commonly used non-surgical approaches for the treatment of hemorrhoids.
The drugs segment has been gaining traction in recent years to avoid post-surgical pain, which is expected to grow steadily during the forecast period.
The band ligators segment dominated the global hemorrhoid treatment market with a dominant market share and is expected to maintain the prominence of significant CAGR in the forecast period. The increasing prevalence of hemorrhoids, growing research activities, and new product launches are enhancing the global market expansion. Band ligators offer better solutions for severe and internal hemorrhoids. Band ligators are effective and provide better outcomes, driving segment growth. According to a research study, Rubber band ligation versus hemorrhoidectomy for treatment of grade II-III hemorrhoids, the hemorrhoidectomy provides better symptom control but with more post-surgical complications, whereas very few complications are observed with band ligators.
The external hemorrhoids segment dominated the global hemorrhoid treatment market due to its high prevalence globally. The internal hemorrhoids are developed inside the rectum and are less common than the external hemorrhoids. In most cases, internal hemorrhoids are preferably treated with over-the-counter products.
The hospital pharmacies segment dominated global revenue with a significant market share. The government and the hospital pharmacies support hospitals, which mainly collaborate with pharmaceuticals, boosting the global market expansion.
Online pharmacies have gained traction in recent years due to people's widespread adoption of digital platforms worldwide. Online pharmacies are expected to have prominent growth during the forecast period due to the discounts, offers, and other benefits digital distributors provide.
The hospital segment held the dominant market share in the global market revenue due to the presence of various services and advanced technological devices for the treatment of hemorrhoids. People highly prefer hospitals for treatment due to the presence of skilled healthcare professionals, which fuels the segment's growth by raising the global hemorrhoid treatment market share.
The European region dominated the global hemorrhoid market due to the rising prevalence of hemorrhoids. The presence of advanced healthcare infrastructure with technological advancements in hemorrhoid treatment devices and growing awareness among the people is enhancing early-stage detection, which supports hemorrhoid treatment by raising the global market value.
The North American region is expected to have the fastest growth during the forecast period due to significant market players and the disease's growing prevalence. The growing awareness among the people regarding the various treatment options due to the government initiatives fuels the regional market growth.
The growing healthcare expenditure in countries like Japan, China, and India are enhancing the expansion of the hemorrhoid treatment market in the Asia Pacific region during the forecast period the increasing research activities to develop innovative, effective treatment procedures that augment the future market growth.
Boston Scientific Corporation, Medtronic Plc, Cook Medical, Integra LifeSciences, CONMED Corporation, Johnson & Johnson, Allergan, GlaxoSmithKline plc, Pfizer Inc., Taro Pharmaceuticals Inc are some of the key players in the global market.
By Treatment Type
By Device Type
By Type
By Distribution Channel
By End-Use
By Region
Frequently Asked Questions
Market size can vary, and it's influenced by factors like the prevalence of hemorrhoids, awareness, and advancements in treatment options. The market is generally substantial due to the commonality of the condition.
Advances may include minimally invasive procedures, improved medications, and a better understanding of the underlying causes. Research and development in this field continue to evolve.
Treatment options include lifestyle changes (diet, exercise), topical medications, over-the-counter creams, procedures like rubber band ligation, sclerotherapy, and surgical interventions for severe cases.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region